Abstract, Snapshot, Market Analysis & Market Definition: ICAD (Intracranial Atherosclerotic Disease) Pathology Market
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%. ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%. North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%. Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. In 2018, the global ICAD (Intracranial Atherosclerotic Disease) Pathology market size was 145.8 million US$ and it is expected to reach 263.1 million US$ by the end of 2025, with a CAGR of 8.8% during 2019-2025. This report focuses on the global ICAD (Intracranial Atherosclerotic Disease) Pathology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the ICAD (Intracranial Atherosclerotic Disease) Pathology development in United States, Europe and China.
Market Segmentation, Outlook & Regional Insights: ICAD (Intracranial Atherosclerotic Disease) Pathology Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
primarily split into
Stent
PTA Balloon
Segmentation by Application: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Hospital
Clinic
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Key Players, Recent Developments & Sector Viewpoints: ICAD (Intracranial Atherosclerotic Disease) Pathology Market
Stryker
Balt
TERUMO
MicroPort
Acandis
Key Insights Covered: Exhaustive ICAD (Intracranial Atherosclerotic Disease) Pathology Market
1. Market size (sales, revenue and growth rate) of ICAD (Intracranial Atherosclerotic Disease) Pathology industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of ICAD (Intracranial Atherosclerotic Disease) Pathology industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of ICAD (Intracranial Atherosclerotic Disease) Pathology industry.
Research Methodology: ICAD (Intracranial Atherosclerotic Disease) Pathology Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.